Compare BNR & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | CPSH |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.4M | 90.8M |
| IPO Year | 2019 | 1995 |
| Metric | BNR | CPSH |
|---|---|---|
| Price | $9.31 | $4.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 4.2K | ★ 277.6K |
| Earning Date | 06-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 113.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $111.65 | $16.41 |
| Revenue Next Year | N/A | $20.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.79 | $2.87 |
| 52 Week High | $41.72 | $14.39 |
| Indicator | BNR | CPSH |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 43.55 |
| Support Level | $8.69 | $3.10 |
| Resistance Level | $10.00 | $4.90 |
| Average True Range (ATR) | 0.52 | 0.27 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 50.58 | 53.85 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.